Currency In JPY
| Previous Close | 2,413.5 |
| Open | 2,452.5 |
| Day High | 2,463.5 |
| Day Low | 2,418 |
| 52-Week High | 2,912 |
| 52-Week Low | 2,109 |
| Volume | 973,300 |
| Average Volume | 1.6M |
| Market Cap | 1.27T |
| PE | 15.61 |
| EPS | 155.37 |
| Moving Average 50 Days | 2,371.01 |
| Moving Average 200 Days | 2,470.92 |
| Change | 11.5 |
Kyowa Kirin to Regain Control of Rocatinlimab Development and Commercialization Program, Demonstrating Strong Commitment to Address High Unmet Medical Need in Atopic Dermatitis
GlobeNewswire Inc.
Jan 30, 2026 1:00 PM GMT
Kyowa Kirin affirms commitment to developing rocatinlimab as a life-changing differentiated asset with significant market potential.Rocatinlimab’s novel approach as an investigational T-cell rebalancing therapy directly targeting the OX40 receptor ex